Nexpoint Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Nexpoint Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,500	Closed	-$485K	–	195
2021 Q1	$485K	Hold	5,500	–	–	0.13%	91
2020 Q4	$526K	Hold	5,500	–	–	0.17%	102
2020 Q3	$624K	Hold	5,500	–	–	0.14%	96
2020 Q2	$544K	Hold	5,500	–	–	0.12%	110
2020 Q1	$354K	Sell	5,500 -2,750	-33%	-$193K	0.07%	150
2019 Q4	$492K	Buy	+8,250	New	+$509K	0.04%	202

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Nexpoint Asset Management's TNDM Position: Q2 2021 in Review

Nexpoint Asset Management sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 5,500 shares — an estimated $485K sold.

Nexpoint Asset Management first reported a position in TNDM in Q4 2019 and held it in 6 quarters. The position peaked at $624K in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

Nexpoint Asset Management reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
Nexpoint Asset Management sold 5,500 Tandem Diabetes Care shares in Q2 2021, an estimated $485K.
Nexpoint Asset Management first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 6 quarters.
Nexpoint Asset Management's Tandem Diabetes Care position peaked at $624K in Q3 2020.
303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Nexpoint Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.